Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | FPR1 | P21462 | 1/20 | 0.56 |
| ▸ | MMP13 | P45452 | 2/20 | 0.53 |
| ▸ | MMP12 | P39900 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | MMP2 | P08253 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.50 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.50 |
| ▸ | ELANE | P08246 | 1/20 | 0.50 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.50 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10338386 | 0.98 | ALDH1A1 (0.54) | ALDH1A1HSD17B10FPR1MMP13MMP12 | |
| SCHEMBL2338220 | 0.83 | CA2 (0.52) | ALDH1A1HSD17B10FPR1MMP13MMP12 | |
| SCHEMBL3929825 | 0.83 | ALDH1A1 (0.58) | ALDH1A1HSD17B10FPR1MMP13SMN1; SMN2 | |
| SCHEMBL581477 | 0.83 | ALDH1A1 (0.57) | ALDH1A1HSD17B10FPR1MMP13SMN1; SMN2 | |
| SCHEMBL1137128 | 0.82 | LMNA (0.47) | ALDH1A1HSD17B10FPR1MMP13MMP12 | |
| SCHEMBL2337040 | 0.82 | KMT2A (0.46) | ALDH1A1HSD17B10FPR1MMP13MMP12 | |
| SCHEMBL831127 | 0.82 | KMT2A (0.51) | MMP13MMP12SMN1; SMN2NPC1POLB | |
| SCHEMBL3267907 | 0.82 | KMT2A (0.69) | ALDH1A1HSD17B10FPR1MMP13MMP12 | |
| SCHEMBL2338295 | 0.82 | KMT2A (0.46) | ALDH1A1HSD17B10FPR1MMP13MMP12 | |
| SCHEMBL3237371 | 0.82 | TSHR (0.56) | ALDH1A1HSD17B10MMP13MMP12TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078296-A1 | SUSTAINED-RELEASE SCALE INHIBITORS | Materials Engineering and Technical Support Services (US) | 2026-03-19 | — | — | US | claimed |
| WO-2024059615-A2 | SUSTAINED-RELEASE SCALE INHIBITORS | MATERIALS ENGINEERING AND TECHNICAL SUPPORT SERVICES CORPORATION (US) | 2024-03-21 | — | — | WO | claimed |
| CN-112831173-B | Composite material for automobile spoiler and preparation method thereof | 无锡井上华光汽车部件有限公司 | 2021-10-15 | — | — | CN | claimed |
| CN-112831173-A | Composite material for automobile spoiler and preparation method thereof | 无锡井上华光汽车部件有限公司 | 2021-05-25 | — | — | CN | claimed |
| US-9090658-B2 | Base-substituted benzylamine analogs for use as coagulation factor Xa inhibitors, the production and use thereof | THE MEDICINES COMPANY (LEIPZIG) GMBH (DE) | 2015-07-28 | — | — | US | claimed |
| EP-1664089-B1 | BASE-SUBSTITUTED BENZYLAMINE ANALOGS FOR USE AS COAGULATION FACTOR XA INHIBITORS, THE PRODUCTION AND USE THEREOF | MEDICINES CO LEIPZIG GMBH (DE) | 2011-11-16 | — | — | EP | claimed |
| US-20110264218-A1 | INTERVERTEBRAL BODY IMPLANT, INSTRUMENT AND METHOD | SPINECRAFT, LLC, A LIMITED LIABILITY COMPANY IN DELAWARE | 2011-10-27 | — | — | US | claimed |
| EP-2292640-A2 | Base-substituted benzylamine analogs for use as coagulation factor Xa inhibitors, the production and use thereof | The Medicines Company (Leipzig) GmbH (DE) | 2011-03-09 | — | — | EP | claimed |
| US-20070066539-A1 | Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof | THE MEDICINES COMPANY (LEIPZIG) GMBH (DE) | 2007-03-22 | — | — | US | claimed |
| EP-1664089-A1 | BASE-SUBSTITUTED BENZYLAMINE ANALOGS FOR USE AS COAGULATION FACTOR XA INHIBITORS, THE PRODUCTION AND USE THEREOF | Curacyte Chemistry GmbH (DE) | 2006-06-07 | — | — | EP | claimed |
| WO-2005026198-A1 | BASE-SUBSTITUTED BENZYLAMINE ANALOGS FOR USE AS COAGULATION FACTOR XA INHIBITORS, THE PRODUCTION AND USE THEREOF | CURACYTE CHEMISTRY GMBH (DE) | 2005-03-24 | — | — | WO | claimed |
| US-4637833-A | OIL WELLS, GAS WELLS | PHILLIPS PETROLEUM CO. (US) | 1987-01-20 | — | — | US | claimed |
| JP-2078655-A | — | — | None | — | — | JP | disclosed |
| US-20260078296-A1 | SUSTAINED-RELEASE SCALE INHIBITORS | Materials Engineering and Technical Support Services (US) | 2026-03-19 | — | — | US | disclosed |
| EP-4182399-B1 | ALKALINE EARTH METAL MINERALS AS CARRIERS FOR SURFACTANTS IN DRILLING FLUIDS | OMYA INT AG (CH) | 2025-09-03 | — | — | EP | disclosed |
| US-12319866-B2 | Alkaline earth metal minerals as carriers for surfactants in drilling fluids | OMYA INTERNATIONAL AG (CH) | 2025-06-03 | — | — | US | disclosed |
| JP-H0278655-A | PRODUCTION OF P-TOLUENESULFONYLACETIC ACID | MITSUI TOATSU CHEM INC | 1990-03-19 | — | — | JP | disclosed |
| US-4837316-A | ANTIULCER AGENTS | FUJIREBIO KABUSHIKI KAISHA (JP) | 1989-06-06 | — | — | US | disclosed |
| US-4637833-A | OIL WELLS, GAS WELLS | PHILLIPS PETROLEUM CO. (US) | 1987-01-20 | — | — | US | disclosed |
| US-4637833-A | OIL WELLS, GAS WELLS | PHILLIPS PETROLEUM CO. (US) | 1987-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078296-A1 | SUSTAINED-RELEASE SCALE INHIBITORS | CEL, TST, CD44 | ALDH1A1 1392/4885HSD17B10 349/4885FPR1 3905/4885 |
| US-20070066539-A1 | Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof | F12, F2, F11 | ALDH1A1 690/4885HSD17B10 2025/4885FPR1 831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.